Chemical basis of hashish activity
- PMID: 4987683
- DOI: 10.1126/science.169.3945.611
Chemical basis of hashish activity
Abstract
A sample of hashish was extracted consecutively with petroleum ether, benzene, and methanol. When tested intravenously in monkeys only the petroleum-ether fraction was active. This material was further fractionated. The only active compound isolated was Delta(1)-tetrahydrocannabinol. Cannabinol, cannabidiol, cannabichromene, cannabigerol, and cannabicyclol when administered together with Delta(1)-tetrahydrocannabinol do not cause a change in the activity of the latter, under the experimental conditions used. These results provide evidence that, except for Delta(1)-tetrahydrocannabinol, no other major, psychotomimetically active compounds are present in hashish.
Similar articles
-
Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene.J Pharm Sci. 1975 May;64(5):810-4. doi: 10.1002/jps.2600640517. J Pharm Sci. 1975. PMID: 1151651
-
Behavioral effects in monkeys of racemates of two biologically active marijuana constituents.Science. 1968 Jun 28;160(3835):1467-9. doi: 10.1126/science.160.3835.1467. Science. 1968. PMID: 4968256
-
Sedative activity of cannabis in relation to its delta'-trans-tetrahydrocannabinol and cannabidiol content.Br J Pharmacol. 1981 Apr;72(4):649-56. doi: 10.1111/j.1476-5381.1981.tb09145.x. Br J Pharmacol. 1981. PMID: 6269680 Free PMC article.
-
Molecular Pharmacology of Phytocannabinoids.Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Prog Chem Org Nat Prod. 2017. PMID: 28120231 Review.
-
Chemistry of marihuana.Pharmacol Rev. 1971 Dec;23(4):265-71. Pharmacol Rev. 1971. PMID: 5134015 Review. No abstract available.
Cited by
-
Regulation of DNA Methylation by Cannabidiol and Its Implications for Psychiatry: New Insights from In Vivo and In Silico Models.Genes (Basel). 2022 Nov 20;13(11):2165. doi: 10.3390/genes13112165. Genes (Basel). 2022. PMID: 36421839 Free PMC article. Review.
-
The effect of delta1-tetrahydrocannabinol on the release of (3H-(-)-noradrenaline from the isolated vas deferens of the rat.Br J Pharmacol. 1974 Oct;52(2):233-6. doi: 10.1111/j.1476-5381.1974.tb09705.x. Br J Pharmacol. 1974. PMID: 4451818 Free PMC article.
-
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms.Neuropsychopharmacology. 2011 Mar;36(4):827-36. doi: 10.1038/npp.2010.222. Epub 2010 Dec 8. Neuropsychopharmacology. 2011. PMID: 21150914 Free PMC article. Clinical Trial.
-
Phytocannabinoids: General Aspects and Pharmacological Potential in Neurodegenerative Diseases.Curr Neuropharmacol. 2021;19(4):449-464. doi: 10.2174/1570159X18666200720172624. Curr Neuropharmacol. 2021. PMID: 32691712 Free PMC article. Review.
-
Cannabidiol and Other Cannabinoids in Demyelinating Diseases.Int J Mol Sci. 2021 Mar 15;22(6):2992. doi: 10.3390/ijms22062992. Int J Mol Sci. 2021. PMID: 33804243 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
